- Comptes-Rendus de Congrès
- Published:
Congrès 2004 de l’American Urological Association San Francisco, Californie, (8–13 Mai 2004)
Andrologie volume 14, pages 348–353 (2004)
References
GIULIANO F., ZERBIB M., ROSEN R.: Erectile dysfunction (ED) in urological practice settings: prevalence, severity according to the IIEF-5 and distress in 1303 patients. J. Urol., 2004: 171, 871A.
MICHL U., GRAEFEN M., PALISAAR J. et al.: Erection, potency, and sexual intercourse following unilateral nerve sparing prostatectomy with n.suralis transplantation contralateral compared to nerve sparing prostatectomy: a critical analysis of preoperative potent men. J. Urol., 2004: 171, 890A.
LEVINE L., Mc CULLOUGH A., PADMA-NATHAN H.: Longitudinal randomized placebo-controlled study of the return of nocturnal erections after nerve-sparing radical prostatectomy in men treated with nightly sildenafil citrate. J. Urol., 2004: 171, 875A.
SOMMER F., ENGELMANN U.: What are the long term effects on erectile dysfunction of taking sildenafil on a daily basis? J. Urol., 2004: 171, 903A.
SOMMER F., KLOTZ T., MATHERS M., BONDARENKO B., CASPERS H., ENGELMANN U.: Which PDE-5 inhibitor do patients prefer? A comparative randomized placebo-controlled multicenter study. J. Urol., 2004: 171, 1192A.
PORST H., KLEINGARN M.: The three PDE-5 inhibitors sildenafil, tadalafil, and vardenafil — results of a comparative preference trial in 222 patients with erectile dysfunction. J. Urol., 2004: 171, 1193A.
CARSON C.: Initial success with AMS 700 series inflatable penile prosthesis with inhibizone antibiotic surface treatment: a retrospective review of revision cases: incidence and comparative results versus non-treated devices. J. Urol., 2004: 171, 894A.
WOLTER C., RAJPURKAR A., KENDIRCI M., DHABUWALA C., HELLSTROM W.: Hydrophilic-coated inflatable penile prosthesis: one-year experience. J. Urol., 2004: 171, 896A.
SHAW K., MOREY A., JONES L., HAKIM L., SHANNON S., HELLSTROM W.: Synchronous prosthetic implantation through a trans-scrotal incision: an outcome analysis. J. Urol., 2004: 171, 898A.
LI M., ROSEN R.: LUTS and male sexual dysfunction in Asia. J. Urol., 2004: 171, 873A.
BARADA J., LEWIS R., WAGNER G.: Should the condition of premature ejaculation be renamed? J. Urol., 2004: 171, 881A.
ARAUJO A., O’DONNELL A., BRAMBILLA D., SIMSON W., McKINLAY J.: Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachussets Male Aging Study. J. Urol., 2004: 171, 1616A.
BIVALACQUA T., USTA M., CHAMPION H., DENG W., KADOWITZ P., HELLSTROM W.: Mesenchymal stem cells alone or modified with eNOS restore erectile function in the aged rat: cell-based gene therapy for erectile dysfunction. J. Urol., 2004: 171, 1417A.
MAY F., WEIDNER N., MATIASEK K. et al.: Bridging the gap: GDNF-hypersecreting Schwann cell grafts restore erectile function after ablation of cavernous nerve segments. J. Urol., 2004: 171, 1425A.
BIVALACQUA T., USTA M., CHAMPION H. et al.: RhoA/Rhokinase suppresses endothelial nitric oxide synthase in the penis: novel mechanism for diabetic-associated erectile dysfunction. J. Urol., 2004: 171, 1411A.
FLESHNER N., HARVEY M., ADOMAT H., WOOD C., HERSEY K., GUNS E.: Evidence for pharmacological contamination of herbal erectile function products with type 5 phosphodiesterase (PDE-5) inhibitors. J. Urol., 2004: 171, 1190A.
THURAIRAJA R., BARRASS B., PERSAD R.: Obtaining herbal remedies for erectile dysfunction from the internet is a potentially dangerous sexual practice. J. Urol., 2004: 171, 1191A.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hellstrom, W.J., Buvat, J. Congrès 2004 de l’American Urological Association San Francisco, Californie, (8–13 Mai 2004). Androl. 14, 348–353 (2004). https://doi.org/10.1007/BF03034925
Issue Date:
DOI: https://doi.org/10.1007/BF03034925